Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Jun;91(6):2453–2462. doi: 10.1172/JCI116480

A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.

M L Hartman 1, P E Clayton 1, M L Johnson 1, A Celniker 1, A J Perlman 1, K G Alberti 1, M O Thorner 1
PMCID: PMC443305  PMID: 8514857

Abstract

To determine if insulin-like growth factor I (IGF-I) inhibits pulsatile growth hormone (GH) secretion in man, recombinant human IGF-I (rhIGF-I) was infused for 6 h at 10 micrograms.kg-1.h-1 during a euglycemic clamp in 10 normal men who were fasted for 32 h to enhance GH secretion. Saline alone was infused during an otherwise identical second admission as a control. As a result of rhIGF-I infusion, total and free IGF-I concentrations increased three- and fourfold, respectively. Mean GH concentrations fell from 6.3 +/- 1.6 to 0.59 +/- 0.07 micrograms/liter after 120 min. GH secretion rates, calculated by a deconvolution algorithm, decreased with a t 1/2 of 16.6 min and remained suppressed thereafter. Suppression of GH secretion rates occurred within 60 min when total and free IGF-I concentrations were 1.6-fold and 2-fold above baseline levels, respectively, and while glucose infusion rates were < 1 mumol.kg-1.min-1. During saline infusion, GH secretion rates remained elevated. Infusion of rhIGF-I decreased the mass of GH secreted per pulse by 84% (P < 0.01) and the number of detectable GH secretory pulses by 32% (P < 0.05). Plasma insulin and glucagon decreased to nearly undetectable levels after 60 min of rhIGF-I. Serum free fatty acids, beta-hydroxybutyrate, and acetoacetate were unaffected during the first 3 h of rhIGF-I but decreased thereafter to 52, 32, and 50% of levels observed during saline. We conclude that fasting-enhanced GH secretion is rapidly suppressed by a low-dose euglycemic infusion of rhIGF-I. This effect of rhIGF-I is likely mediated through IGF-I receptors independently of its insulin-like metabolic actions.

Full text

PDF
2453

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe H., Molitch M. E., Van Wyk J. J., Underwood L. E. Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats. Endocrinology. 1983 Oct;113(4):1319–1324. doi: 10.1210/endo-113-4-1319. [DOI] [PubMed] [Google Scholar]
  2. Bar R. S., Boes M., Clemmons D. R., Busby W. H., Sandra A., Dake B. L., Booth B. A. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart. Endocrinology. 1990 Jul;127(1):497–499. doi: 10.1210/endo-127-1-497. [DOI] [PubMed] [Google Scholar]
  3. Berelowitz M., Szabo M., Frohman L. A., Firestone S., Chu L., Hintz R. L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science. 1981 Jun 12;212(4500):1279–1281. doi: 10.1126/science.6262917. [DOI] [PubMed] [Google Scholar]
  4. Caro J. F., Poulos J., Ittoop O., Pories W. J., Flickinger E. G., Sinha M. K. Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J Clin Invest. 1988 Apr;81(4):976–981. doi: 10.1172/JCI113451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Casanueva F. F. Physiology of growth hormone secretion and action. Endocrinol Metab Clin North Am. 1992 Sep;21(3):483–517. [PubMed] [Google Scholar]
  6. Ceda G. P., Davis R. G., Rosenfeld R. G., Hoffman A. R. The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II. Endocrinology. 1987 Apr;120(4):1658–1662. doi: 10.1210/endo-120-4-1658. [DOI] [PubMed] [Google Scholar]
  7. Clemmons D. R., Smith-Banks A., Underwood L. E. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J Clin Endocrinol Metab. 1992 Jul;75(1):234–238. doi: 10.1210/jcem.75.1.1619015. [DOI] [PubMed] [Google Scholar]
  8. Clemmons D. R., Underwood L. E. Nutritional regulation of IGF-I and IGF binding proteins. Annu Rev Nutr. 1991;11:393–412. doi: 10.1146/annurev.nu.11.070191.002141. [DOI] [PubMed] [Google Scholar]
  9. Daughaday W. H., Mariz I. K., Blethen S. L. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab. 1980 Oct;51(4):781–788. doi: 10.1210/jcem-51-4-781. [DOI] [PubMed] [Google Scholar]
  10. Daughaday W. H., Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev. 1989 Feb;10(1):68–91. doi: 10.1210/edrv-10-1-68. [DOI] [PubMed] [Google Scholar]
  11. DeFronzo R. A., Tobin J. D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214–E223. doi: 10.1152/ajpendo.1979.237.3.E214. [DOI] [PubMed] [Google Scholar]
  12. Dohm G. L., Elton C. W., Raju M. S., Mooney N. D., DiMarchi R., Pories W. J., Flickinger E. G., Atkinson S. M., Jr, Caro J. F. IGF-I--stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM. Diabetes. 1990 Sep;39(9):1028–1032. doi: 10.2337/diab.39.9.1028. [DOI] [PubMed] [Google Scholar]
  13. Faria A. C., Veldhuis J. D., Thorner M. O., Vance M. L. Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin. J Clin Endocrinol Metab. 1989 Mar;68(3):535–541. doi: 10.1210/jcem-68-3-535. [DOI] [PubMed] [Google Scholar]
  14. Frohman L. A., Downs T. R., Clarke I. J., Thomas G. B. Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. Spontaneous secretion and response to insulin-induced hypoglycemia. J Clin Invest. 1990 Jul;86(1):17–24. doi: 10.1172/JCI114681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Guler H. P., Schmid C., Zapf J., Froesch E. R. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2868–2872. doi: 10.1073/pnas.86.8.2868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Guler H. P., Zapf J., Froesch E. R. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med. 1987 Jul 16;317(3):137–140. doi: 10.1056/NEJM198707163170303. [DOI] [PubMed] [Google Scholar]
  17. Harel Z., Tannenbaum G. S. Synergistic interaction between insulin-like growth factors-I and -II in central regulation of pulsatile growth hormone secretion. Endocrinology. 1992 Aug;131(2):758–764. doi: 10.1210/endo.131.2.1639021. [DOI] [PubMed] [Google Scholar]
  18. Harrison J., Hodson A. W., Skillen A. W., Stappenbeck R., Agius L., Alberti K. G. Blood glucose, lactate, pyruvate, glycerol, 3-hydroxybutyrate and acetoacetate measurements in man using a centrifugal analyser with a fluorimetric attachment. J Clin Chem Clin Biochem. 1988 Mar;26(3):141–146. doi: 10.1515/cclm.1988.26.3.141. [DOI] [PubMed] [Google Scholar]
  19. Hartman M. L., Veldhuis J. D., Johnson M. L., Lee M. M., Alberti K. G., Samojlik E., Thorner M. O. Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men. J Clin Endocrinol Metab. 1992 Apr;74(4):757–765. doi: 10.1210/jcem.74.4.1548337. [DOI] [PubMed] [Google Scholar]
  20. Hartman M. L., Veldhuis J. D., Vance M. L., Faria A. C., Furlanetto R. W., Thorner M. O. Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy. J Clin Endocrinol Metab. 1990 May;70(5):1375–1384. doi: 10.1210/jcem-70-5-1375. [DOI] [PubMed] [Google Scholar]
  21. Ho K. Y., Veldhuis J. D., Johnson M. L., Furlanetto R., Evans W. S., Alberti K. G., Thorner M. O. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest. 1988 Apr;81(4):968–975. doi: 10.1172/JCI113450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hoeffler J. P., Hicks S. A., Frawley L. S. Existence of somatotrope subpopulations which are differentially responsive to insulin-like growth factor I and somatostatin. Endocrinology. 1987 May;120(5):1936–1941. doi: 10.1210/endo-120-5-1936. [DOI] [PubMed] [Google Scholar]
  23. Jacob R., Barrett E., Plewe G., Fagin K. D., Sherwin R. S. Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin. J Clin Invest. 1989 May;83(5):1717–1723. doi: 10.1172/JCI114072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kawai K., Suzuki S., Takano K., Hizuka N., Watanabe Y., Yamashita K. Effects of insulin-like growth factor-I on insulin and glucagon release from isolated perfused rat pancreas. Endocrinol Jpn. 1990 Dec;37(6):867–874. doi: 10.1507/endocrj1954.37.867. [DOI] [PubMed] [Google Scholar]
  25. Lamberts S. W., den Holder F., Hofland L. J. The interrelationship between the effects of insulin-like growth factor I and somatostatin on growth hormone secretion by normal rat pituitary cells: the role of glucocorticoids. Endocrinology. 1989 Feb;124(2):905–911. doi: 10.1210/endo-124-2-905. [DOI] [PubMed] [Google Scholar]
  26. Leahy J. L., Vandekerkhove K. M. Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology. 1990 Mar;126(3):1593–1598. doi: 10.1210/endo-126-3-1593. [DOI] [PubMed] [Google Scholar]
  27. Lieberman S. A., Bukar J., Chen S. A., Celniker A. C., Compton P. G., Cook J., Albu J., Perlman A. J., Hoffman A. R. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans. J Clin Endocrinol Metab. 1992 Jul;75(1):30–36. doi: 10.1210/jcem.75.1.1377706. [DOI] [PubMed] [Google Scholar]
  28. Namba H., Morita S., Melmed S. Insulin-like growth factor-I action on growth hormone secretion and messenger ribonucleic acid levels: interaction with somatostatin. Endocrinology. 1989 Apr;124(4):1794–1799. doi: 10.1210/endo-124-4-1794. [DOI] [PubMed] [Google Scholar]
  29. O'Brien P. C., Shampo M. A. Statistical considerations for performing multiple tests in a single experiment. 3. Repeated measures over time. Mayo Clin Proc. 1988 Sep;63(9):918–920. doi: 10.1016/s0025-6196(12)62696-2. [DOI] [PubMed] [Google Scholar]
  30. Otonkoski T., Knip M., Wong I., Simell O. Effects of growth hormone and insulin-like growth factor I on endocrine function of human fetal islet-like cell clusters during long-term tissue culture. Diabetes. 1988 Dec;37(12):1678–1683. doi: 10.2337/diab.37.12.1678. [DOI] [PubMed] [Google Scholar]
  31. Press M., Caprio S., Tamborlane W. V., Bhushan R., Thorner M., Vale W., Rivier J., Sherwin R. S. Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes. 1992 Jan;41(1):17–21. doi: 10.2337/diab.41.1.17. [DOI] [PubMed] [Google Scholar]
  32. Rosenfeld R. G., Ceda G., Wilson D. M., Dollar L. A., Hoffman A. R. Characterization of high affinity receptors for insulin-like growth factors I and II on rat anterior pituitary cells. Endocrinology. 1984 May;114(5):1571–1575. doi: 10.1210/endo-114-5-1571. [DOI] [PubMed] [Google Scholar]
  33. Shibasaki T., Yamauchi N., Hotta M., Masuda A., Imaki T., Demura H., Ling N., Shizume K. In vitro release of growth hormone-releasing factor from rat hypothalamus: effect of insulin-like growth factor-1. Regul Pept. 1986 Aug;15(1):47–53. doi: 10.1016/0167-0115(86)90074-1. [DOI] [PubMed] [Google Scholar]
  34. Sinha M. K., Buchanan C., Leggett N., Martin L., Khazanie P. G., Dimarchi R., Pories W. J., Caro J. F. Mechanism of IGF-I-stimulated glucose transport in human adipocytes. Demonstration of specific IGF-I receptors not involved in stimulation of glucose transport. Diabetes. 1989 Oct;38(10):1217–1225. doi: 10.2337/diab.38.10.1217. [DOI] [PubMed] [Google Scholar]
  35. Takano K., Hizuka N., Shizume K., Asakawa K., Fukuda I., Demura H. Repeated sc administration of recombinant human insulin-like growth factor I (IGF-I) to human subjects for 7 days. Growth Regul. 1991 Mar;1(1):23–28. [PubMed] [Google Scholar]
  36. Tannenbaum G. S., Guyda H. J., Posner B. I. Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brain. Science. 1983 Apr 1;220(4592):77–79. doi: 10.1126/science.6338593. [DOI] [PubMed] [Google Scholar]
  37. Thorner M. O., Vance M. L., Hartman M. L., Holl R. W., Evans W. S., Veldhuis J. D., Van Cauter E., Copinschi G., Bowers C. Y. Physiological role of somatostatin on growth hormone regulation in humans. Metabolism. 1990 Sep;39(9 Suppl 2):40–42. doi: 10.1016/0026-0495(90)90207-s. [DOI] [PubMed] [Google Scholar]
  38. Van Schravendijk C. F., Foriers A., Van den Brande J. L., Pipeleers D. G. Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinology. 1987 Nov;121(5):1784–1788. doi: 10.1210/endo-121-5-1784. [DOI] [PubMed] [Google Scholar]
  39. Veldhuis J. D., Johnson M. L. Deconvolution analysis of hormone data. Methods Enzymol. 1992;210:539–575. doi: 10.1016/0076-6879(92)10028-c. [DOI] [PubMed] [Google Scholar]
  40. Winer L. M., Shaw M. A., Baumann G. Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion. J Clin Endocrinol Metab. 1990 Jun;70(6):1678–1686. doi: 10.1210/jcem-70-6-1678. [DOI] [PubMed] [Google Scholar]
  41. Yamashita S., Melmed S. Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels. Endocrinology. 1986 Jan;118(1):176–182. doi: 10.1210/endo-118-1-176. [DOI] [PubMed] [Google Scholar]
  42. Young S. C., Underwood L. E., Celniker A., Clemmons D. R. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults. J Clin Endocrinol Metab. 1992 Aug;75(2):603–608. doi: 10.1210/jcem.75.2.1379258. [DOI] [PubMed] [Google Scholar]
  43. Zapf J., Hauri C., Waldvogel M., Froesch E. R. Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. J Clin Invest. 1986 Jun;77(6):1768–1775. doi: 10.1172/JCI112500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Zapf J., Schmid C., Guler H. P., Waldvogel M., Hauri C., Futo E., Hossenlopp P., Binoux M., Froesch E. R. Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. J Clin Invest. 1990 Sep;86(3):952–961. doi: 10.1172/JCI114797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Zenobi P. D., Graf S., Ursprung H., Froesch E. R. Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion. J Clin Invest. 1992 Jun;89(6):1908–1913. doi: 10.1172/JCI115796. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES